Ameeta Parekh
YOU?
Author Swipe
View article: B-309 Validation and Application of a Gas Chromatography–Mass Spectrometry Method in Emergency Drug Testing
B-309 Validation and Application of a Gas Chromatography–Mass Spectrometry Method in Emergency Drug Testing Open
Background Qualitative urine drug screening is important in identifying or ruling out the presence of toxic substances in suspected overdose cases. However, high-throughput immunoassay panels cover only a limited range of drug classes. Whe…
View article: Postoperative venous thromboembolism in transgender patients receiving estrogen-based hormone therapy
Postoperative venous thromboembolism in transgender patients receiving estrogen-based hormone therapy Open
View article: Public-private partnerships in transplant drug development
Public-private partnerships in transplant drug development Open
The Transplant Therapeutics Consortium (TTC), a public-private partnership (PPP) led by the Critical Path Institute (C-Path), recently published a whitepaper titled "The Importance of Drug Safety and Tolerability in the Development of New …
View article: The Role of Public–Private Partnerships in Catalyzing the Critical Path
The Role of Public–Private Partnerships in Catalyzing the Critical Path Open
The US Food and Drug Administration (FDA)'s Critical Path Initiative (CPI) was launched in 2004 and aimed at accelerating the stagnating product development pipeline. Subsequently, in 2006, the Critical Path Opportunities List (CPOL) ident…
View article: Catalyzing the critical path initiative: FDA's progress in drug development activities
Catalyzing the critical path initiative: FDA's progress in drug development activities Open
The US Food and Drug Administration (FDA) has directed considerable effort towards modernizing its regulatory processes over the past decade to address the challenges in the drug development sector. Through partnerships and input from stak…